BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23143983)

  • 1. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
    Hanin L
    Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor.
    Hanin L; Bunimovich-Mendrazitsky S
    Math Biosci; 2014 Jan; 247():47-58. PubMed ID: 24211826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative insight into metastatic relapse of breast cancer.
    Hanin L; Pavlova L
    J Theor Biol; 2016 Apr; 394():172-181. PubMed ID: 26801873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Metastasis by Primary Tumor and Acceleration of Metastasis Following Primary Tumor Resection: A Natural Law?
    Hanin L; Rose J
    Bull Math Biol; 2018 Mar; 80(3):519-539. PubMed ID: 29302774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular dormancy in minimal residual disease following targeted therapy.
    Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
    Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel model of dormancy for bone metastatic breast cancer cells.
    Marlow R; Honeth G; Lombardi S; Cariati M; Hessey S; Pipili A; Mariotti V; Buchupalli B; Foster K; Bonnet D; Grigoriadis A; Rameshwar P; Purushotham A; Tutt A; Dontu G
    Cancer Res; 2013 Dec; 73(23):6886-99. PubMed ID: 24145351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
    Demicheli R; Retsky MW; Hrushesky WJ; Baum M
    Nat Clin Pract Oncol; 2007 Dec; 4(12):699-710. PubMed ID: 18037874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer metastasis.
    Scully OJ; Bay BH; Yip G; Yu Y
    Cancer Genomics Proteomics; 2012; 9(5):311-20. PubMed ID: 22990110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer dormancy: a model of early dissemination and late cancer recurrence.
    Páez D; Labonte MJ; Bohanes P; Zhang W; Benhanim L; Ning Y; Wakatsuki T; Loupakis F; Lenz HJ
    Clin Cancer Res; 2012 Feb; 18(3):645-53. PubMed ID: 22156560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated Tumor Cells and Dormancy in Breast Cancer Progression.
    Banys-Paluchowski M; Reinhardt F; Fehm T
    Adv Exp Med Biol; 2020; 1220():35-43. PubMed ID: 32304078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor dormancy and identification of therapeutic targets].
    Li CF; Cao S; Meng SD
    Ai Zheng; 2009 May; 28(5):555-8. PubMed ID: 19624889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?
    Bozza C; Fontanella C; Buoro V; Mansutti M; Aprile G
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):251-65. PubMed ID: 25597501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of prostate metastases: emerging insights.
    Santoni M; Piva F; Scarpelli M; Cheng L; Lopez-Beltran A; Massari F; Iacovelli R; Berardi R; Santini D; Montironi R
    Cancer Metastasis Rev; 2015 Dec; 34(4):765-73. PubMed ID: 26363603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
    Demicheli R
    Semin Cancer Biol; 2001 Aug; 11(4):297-306. PubMed ID: 11513565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
    Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
    APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor dormancy: long-term survival in a hostile environment.
    Quesnel B
    Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy.
    Norton L
    Oncologist; 2005; 10(6):370-81. PubMed ID: 15967831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.